Last reviewed · How we verify
Gelatin Sponge Sheet
The Gelatin Sponge Sheet, marketed by Tianjin Medical University Eye Hospital, is a unique product in the ophthalmic surgical market. Its key strength lies in the key composition patent, which is set to expire in 2028, providing a period of exclusive market protection. The primary risk is the potential increase in competition following the patent expiry, which could erode market share and revenue.
At a glance
| Generic name | Gelatin Sponge Sheet |
|---|---|
| Also known as | gel foam |
| Sponsor | Tianjin Medical University Eye Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- THE COMPARISON OF GELATIN SPONGE TO SUTURE ALONE ON POST OPERATIVE SWELLING AFTER EXTRACTION OF IMPACTED MANDIBULAR THIRD MOLAR. (NA)
- Comparing Two Wound Coverings for Healing and Comfort After Palatal Gum Graft Surgery in Adults (NA)
- Assessment of a Carvacrol-loaded Absorbable Gelatin Sponge Used As a Palatal Dressing Following Free Gingival Graft Harvesting: a Randomized Clinical Study (NA)
- Safety and Efficacy of Thermosensitive Hydroxybutyl Chitosan and 5-fluorouracil Assisted Endoscopic Dacryocystorhinostomy in the Treatment of Chronic Dacryocystitis (PHASE1)
- Alveogyl and Gelatin Sponge in the Management of Pain After Epithelialized Free Gingival Graft Harvesting (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gelatin Sponge Sheet CI brief — competitive landscape report
- Gelatin Sponge Sheet updates RSS · CI watch RSS
- Tianjin Medical University Eye Hospital portfolio CI